Ryan Rauch
Ryan Rauch
believe boston risks scientific
There are some significant risks for Boston Scientific from an integration standpoint, but I believe the combination of Boston Scientific and Guidant makes a lot of sense.
device medical missed small tape
They missed the (forecast) by $1 million, and it's a very choppy tape for small medical device companies.
board boston felt loyalty offers scientific understood
I've been a little perplexed. I've always felt that Boston Scientific offers have been superior. I've not understood the loyalty of Guidant's board to J&J.
huge supporting
We're supporting it because it's a huge opportunity.
buyers current extremely impressed posted quarter results solid stock
We were extremely impressed by the solid results posted in the first quarter and would be buyers of the stock at current levels.